ISSUER CIK 1567892
Keenova Therapeutics plc
Between Aug 1, 2026 and Oct 29, 2026, 1 Keenova Therapeutics plc insiders reported $54.5M of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Goldentree Asset Management LP (10% Owner), with $54.5M.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$54.5MInsider buying
$0.00Insider selling
+$54.5MNet open-market
Oct 16, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 202616:30 | Oct 14, 2026 | — | 10% Owner · +2 joint | P · Buy | $90.00 | +137,000 | 8,579,827 | +2% | +$12.3M | — | — |
| Oct 6, 202616:30 | Sep 24, 2026 | — | 10% Owner · +2 joint | P · BuyLate 12d | $91.00 | +463,000 | 8,442,827 | +6% | +$42.1M | — | — |